Regals Capital Management Lp - Net Worth and Insider Trading

Regals Capital Management Lp Net Worth

The estimated net worth of Regals Capital Management Lp is at least $3 Million dollars as of 2024-05-10. Regals Capital Management Lp is the 10% Owner of Oramed Pharmaceuticals Inc and owns about 1,453,637 shares of Oramed Pharmaceuticals Inc (ORMP) stock worth over $3 Million. Details can be seen in Regals Capital Management Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Regals Capital Management Lp has not made any transactions after 2014-06-06 and currently still holds the listed stock(s).

Transaction Summary of Regals Capital Management Lp

To

Regals Capital Management Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Regals Capital Management Lp owns 2 companies in total, including Oramed Pharmaceuticals Inc (ORMP) , and Legend International Holdings Inc (LGDIQ) .

Click here to see the complete history of Regals Capital Management Lp’s form 4 insider trades.

Insider Ownership Summary of Regals Capital Management Lp

Ticker Comapny Transaction Date Type of Owner
ORMP Oramed Pharmaceuticals Inc 2014-06-06 10 percent owner
LGDIQ Legend International Holdings Inc 2013-02-19 10 percent owner

Regals Capital Management Lp Latest Holdings Summary

Regals Capital Management Lp currently owns a total of 1 stock. Regals Capital Management Lp owns 1,453,637 shares of Oramed Pharmaceuticals Inc (ORMP) as of June 6, 2014, with a value of $3 Million.

Latest Holdings of Regals Capital Management Lp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ORMP Oramed Pharmaceuticals Inc 2014-06-06 1,453,637 2.38 3,459,656

Holding Weightings of Regals Capital Management Lp


Regals Capital Management Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Regals Capital Management Lp has made a total of 0 transactions in Oramed Pharmaceuticals Inc (ORMP) over the past 5 years. The most-recent trade in Oramed Pharmaceuticals Inc is the acquisition of 2,252 shares on June 6, 2014, which cost Regals Capital Management Lp around $9,999.

Insider Trading History of Regals Capital Management Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Regals Capital Management Lp Trading Performance

GuruFocus tracks the stock performance after each of Regals Capital Management Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Regals Capital Management Lp is -12.85%. GuruFocus also compares Regals Capital Management Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Regals Capital Management Lp within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Regals Capital Management Lp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Regals Capital Management Lp

Average Return

Average return per transaction

Outperforming Transactions

1 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.17
Relative Return to S&P 500(%) 5.69

Regals Capital Management Lp Ownership Network

Ownership Network List of Regals Capital Management Lp

No Data

Ownership Network Relation of Regals Capital Management Lp


Regals Capital Management Lp Owned Company Details

What does Oramed Pharmaceuticals Inc do?

Who are the key executives at Oramed Pharmaceuticals Inc?

Regals Capital Management Lp is the 10 percent owner of Oramed Pharmaceuticals Inc. Other key executives at Oramed Pharmaceuticals Inc include director & 10 percent owner Nadav Kidron , Chief Commercial Officer Michael Rabinowitz , and Chief Financial Officer David Silberman .

Oramed Pharmaceuticals Inc (ORMP) Insider Trades Summary

Over the past 18 months, Regals Capital Management Lp made no insider transaction in Oramed Pharmaceuticals Inc (ORMP). Other recent insider transactions involving Oramed Pharmaceuticals Inc (ORMP) include a net purchase of 126,000 shares made by Nadav Kidron , a net sale of 100,000 shares made by Miriam Kidron , and a net purchase of 70,000 shares made by Yadin Rozov .

In summary, during the past 3 months, insiders sold 0 shares of Oramed Pharmaceuticals Inc (ORMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 113,325 shares of Oramed Pharmaceuticals Inc (ORMP) were sold and 196,000 shares were bought by its insiders, resulting in a net purchase of 82,675 shares.

Oramed Pharmaceuticals Inc (ORMP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Oramed Pharmaceuticals Inc Insider Transactions

No Available Data

Regals Capital Management Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Regals Capital Management Lp. You might contact Regals Capital Management Lp via mailing address: 152 West 57th Street, 9th Floor, New York Ny 10019.

Discussions on Regals Capital Management Lp

No discussions yet.